Granulocyte-Macrophage Colony-Stimulating Factor As a Therapeutic Target in Multiple Sclerosis

Overview

Journal Neurol Ther

Publisher Springer

Specialty Neurology

Date 2018 Dec 4

PMID 30506485

Citations 9

Authors

Jehan Aram

Anna Francis

Radu Tanasescu

Cris S Constantinescu

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis is an inflammatory neurodegenerative disease of the central nervous system (CNS) and the most frequent cause of non-traumatic disability in adults in the Western world. Currently, several drugs have been approved for the treatment of multiple sclerosis. While the newer drugs are more effective, they have less favourable safety profiles. Thus, there is a need to identify new targets for effective and safe therapies, particularly in patients with progressive disease for whom no treatments are available. One such target is granulocyte-macrophage colony-stimulating factor (GM-CSF) or its receptor. In this article we review data on the potential role of GM-CSF and GM-CSF inhibition in MS. We discuss the expression and function of GM-CSF and its receptor in the CNS, as well as data from animal studies and clinical trials in MS.

Citing Articles

White matter paramagnetic rim and non-rim lesions share a periventricular gradient in multiple sclerosis: A 7-T imaging study.

Miscioscia A, Treaba C, Barletta V, Herranz E, Sloane J, Barbuti E Mult Scler. 2024; 30(2):166-176.

PMID: 38279672 PMC: 10922980. DOI: 10.1177/13524585231224681.

Inflammatory Cytokines Associated with Multiple Sclerosis Directly Induce Alterations of Neuronal Cytoarchitecture in Human Neurons.

Meyer-Arndt L, Kerkering J, Kuehl T, Infante A, Paul F, Rosiewicz K J Neuroimmune Pharmacol. 2023; 18(1-2):145-159.

PMID: 36862362 PMC: 10485132. DOI: 10.1007/s11481-023-10059-w.

Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy.

Balagopal S, Sasaki K, Kaur P, Nikolaidi M, Ishihara J J Mater Chem B. 2022; 10(37):7491-7511.

PMID: 35912720 PMC: 9518648. DOI: 10.1039/d2tb00592a.

Elevated proportion of TLR2- and TLR4-expressing Th17-like cells and activated memory B cells was associated with clinical activity of cerebral cavernous malformations.

Castro C, Oyamada H, Cafasso M, Lopes L, Monteiro C, Sacramento P J Neuroinflammation. 2022; 19(1):28.

PMID: 35109870 PMC: 8808981. DOI: 10.1186/s12974-022-02385-2.

Oleacein Attenuates the Pathogenesis of Experimental Autoimmune Encephalomyelitis through Both Antioxidant and Anti-Inflammatory Effects.

Gutierrez-Miranda B, Gallardo I, Melliou E, Cabero I, Alvarez Y, Magiatis P Antioxidants (Basel). 2020; 9(11).

PMID: 33233421 PMC: 7700216. DOI: 10.3390/antiox9111161.

References

Harris R, Pettitt A, Schmutz C, Sherrington P, Zuzel M, Cawley J . Granulocyte-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes. J Immunol. 2000; 164(7):3887-93. DOI: 10.4049/jimmunol.164.7.3887. View

Infante-Duarte C, Horton H, Byrne M, Kamradt T . Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol. 2000; 165(11):6107-15. DOI: 10.4049/jimmunol.165.11.6107. View

Biondo M, Nasa Z, Marshall A, Toh B, Alderuccio F . Local transgenic expression of granulocyte macrophage-colony stimulating factor initiates autoimmunity. J Immunol. 2001; 166(3):2090-9. DOI: 10.4049/jimmunol.166.3.2090. View

Lilly M, Zemskova M, Frankel A, Salo J, Kraft A . Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit mediate activation of Jak/Stat signaling and differentiation. Blood. 2001; 97(6):1662-70. DOI: 10.1182/blood.v97.6.1662. View

Cooper M, Fehniger T, Turner S, Chen K, Ghaheri B, Ghayur T . Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001; 97(10):3146-51. DOI: 10.1182/blood.v97.10.3146. View

Hashimoto S, Komuro I, Yamada M, Akagawa K . IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages. J Immunol. 2001; 167(7):3619-25. DOI: 10.4049/jimmunol.167.7.3619. View

McQualter J, Darwiche R, Ewing C, Onuki M, Kay T, Hamilton J . Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med. 2001; 194(7):873-82. PMC: 2193476. DOI: 10.1084/jem.194.7.873. View

Montagnani S, Postiglione L, Giordano-Lanza G, Meglio F, Castaldo C, Sciorio S . Granulocyte macrophage colony stimulating factor (GM-CSF) biological actions on human dermal fibroblasts. Eur J Histochem. 2002; 45(3):219-28. DOI: 10.4081/1632. View

Re F, Belyanskaya S, Riese R, Cipriani B, Fischer F, Granucci F . Granulocyte-macrophage colony-stimulating factor induces an expression program in neonatal microglia that primes them for antigen presentation. J Immunol. 2002; 169(5):2264-73. DOI: 10.4049/jimmunol.169.5.2264. View

10.

Marusic S, Miyashiro J, Douhan 3rd J, Konz R, Xuan D, Pelker J . Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice. Neurosci Lett. 2002; 332(3):185-9. DOI: 10.1016/s0304-3940(02)00947-3. View

11.

Kubista B, Trieb K, Herbacek I, Micksche M . Effect of granulocyte-macrophage colony-stimulating factor on natural-killer cell mediated cytotoxicity. Int J Biochem Cell Biol. 2003; 35(7):1056-60. DOI: 10.1016/s1357-2725(02)00383-7. View

12.

Fitzgerald S, Chi D, Hall H, Reynolds S, Aramide O, Lee S . GM-CSF induction in human lung fibroblasts by IL-1beta, TNF-alpha, and macrophage contact. J Interferon Cytokine Res. 2003; 23(2):57-65. DOI: 10.1089/107999003321455453. View

13.

Churchill L, Friedman B, Schleimer R, Proud D . Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology. 1992; 75(1):189-95. PMC: 1384823. View

14.

Timoshanko J, Kitching A, Semple T, Holdsworth S, Tipping P . Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis. J Am Soc Nephrol. 2005; 16(9):2646-56. DOI: 10.1681/ASN.2004121107. View

15.

Malipiero U, Frei K, Fontana A . Production of hemopoietic colony-stimulating factors by astrocytes. J Immunol. 1990; 144(10):3816-21. View

16.

Bezbradica J, Gordy L, Stanic A, Dragovic S, Hill T, Hawiger J . Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Immunity. 2006; 25(3):487-97. DOI: 10.1016/j.immuni.2006.06.017. View

17.

Jacobsen S, Ruscetti F, Dubois C, Lee J, Boone T, Keller J . Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood. 1991; 77(8):1706-16. View

18.

Parmiani G, Castelli C, Pilla L, Santinami M, Colombo M, Rivoltini L . Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients. Ann Oncol. 2006; 18(2):226-32. DOI: 10.1093/annonc/mdl158. View

19.

Campbell I, Novak U, Cebon J, Layton J, Hamilton J . Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1. J Immunol. 1991; 147(4):1238-46. View

20.

Ponomarev E, Shriver L, Maresz K, Pedras-Vasconcelos J, Verthelyi D, Dittel B . GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J Immunol. 2006; 178(1):39-48. DOI: 10.4049/jimmunol.178.1.39. View